CRVS Stock-Based Compensation
Corvus Pharmaceuticals Inc · Stock-Based Compensation
CRVS Stock-Based Compensation
Latest reported$8.08Mperiod ending
CRVS Stock-Based Comp ($0.00 → $8.08M)
Annual stock-based compensation
High-resolution chart · PNG
CRVS stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 5,330,000 | |
| 3,003,000 | |
| 2,147,000 | |
| 2,692,000 | |
| 4,232,000 | |
| 5,747,000 | |
| 7,348,000 | |
| 7,135,000 | |
| 6,229,000 | |
| 3,828,000 | |
| 428,000 | |
| 0 |